Καναδάς - Αγγλικά - Health Canada

bgp pharma ulc - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b (victoria); haemagglutinin-strain b (yamagata) - suspension - 15mcg; 15mcg; 15mcg; 15mcg - haemagglutinin-strain a (h1n1) 15mcg; haemagglutinin-strain a (h3n2) 15mcg; haemagglutinin-strain b (victoria) 15mcg; haemagglutinin-strain b (yamagata) 15mcg - vaccines

Μάλτα - Αγγλικά - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - a, guangdong, maonan, swl, hong kong, b, washington - suspension for injection in pre-filled syringe - a/guangdong-maonan/swl1536/2019 15 µg a/hong kong/2671/2019 15 µg b/washington/02/2019 15 µg - vaccines

Μάλτα - Αγγλικά - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - influenza vaccine, split virion, inactivated - suspension for injection in pre-filled syringe - influenza vaccine (split virion, inactivated) 15 µg - vaccines

Μάλτα - Αγγλικά - Medicines Authority

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - a, brisbane, h, ivr, kansas, nymc x, phuket, wild type, nymc bx - suspension for injection in pre-filled syringe - a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227 15 µg b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) 15 µg b/austria/1359417/2021 - like strain (b/austria/1359417/2021 bvr-26 15 µg a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022 ivr-238 15 µg - vaccines

Ισραήλ - Αγγλικά - Ministry of Health

abbott medical laboratories ltd, israel - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - suspension for injection - b/phuket/3073/2013 (b/yamagata lineage)-like virus 30 mcg ha / 1 ml; a/darwin/9/2021 (h3n2)-like virus 30 mcg ha / 1 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 30 mcg ha / 1 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 30 mcg ha / 1 ml - influenza, inactivated, split virus or surface antigen - prophylaxis of influenza, especially those who run an increased risk of associated complications. influvac tetra is indicated in adults and children from 6 months of age.

Ισραήλ - Αγγλικά - Ministry of Health

sanofi israel ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - suspension for injection - b/phuket/3073/2013 (b/yamagata lineage)-like virus 30 mcg ha / 1 ml; a/darwin/9/2021 (h3n2)-like virus 30 mcg ha / 1 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 30 mcg ha / 1 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 30 mcg ha / 1 ml - influenza, inactivated, split virus or surface antigen - vaxigrip tetra is indicated for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine for:- active immunisation of adults, including pregnant women, and children from 6 months of age and older- passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women.the use of vaxigrip tetra should be based on official recommendations.

Καναδάς - Αγγλικά - Health Canada

seqirus uk limited - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b (victoria); haemagglutinin-strain b (yamagata) - suspension - 15mcg; 15mcg; 15mcg; 15mcg - haemagglutinin-strain a (h1n1) 15mcg; haemagglutinin-strain a (h3n2) 15mcg; haemagglutinin-strain b (victoria) 15mcg; haemagglutinin-strain b (yamagata) 15mcg - vaccines

Καναδάς - Αγγλικά - Health Canada

seqirus uk limited - haemagglutinin-strain b (victoria); haemagglutinin-strain b (yamagata); haemagglutinin-strain a (h3n2); haemagglutinin-strain a (h1n1) - suspension - 15mcg; 15mcg; 15mcg; 15mcg - haemagglutinin-strain b (victoria) 15mcg; haemagglutinin-strain b (yamagata) 15mcg; haemagglutinin-strain a (h3n2) 15mcg; haemagglutinin-strain a (h1n1) 15mcg - vaccines

Αρμενία - Αγγλικά - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

abbott biologicals b.v. veerweg 12 - influenza vaccine inactivated (surface antigen)-a/brisbane/02/2018 (h1n1) pdm-like strain (a/brisbane/02/2018, ivr-190), a/kansas/14/2017 (h3n2)-like strain (a/ a/kansas/14/2017, nymc x-327), b/colorado/06/2017-like strain (b/ victoria/2/87/ lineage) (b/maryland/15/2016, nymc bx-69 a) - suspension for injection - 15mcg haemagglutinin/dose+ 15mcg haemagglutinin/dose+ 15mcg haemagglutinin/dose

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - split influenza virus, inactivated, containing antigen eqv a/vietnam/1194/2004 (h5n1) - injection, emulsion - split influenza virus, inactivated, containing antigen eqv a/vietnam/1194/2004 (h5n1) 3.75 µg haemagglutinin/dose